Midline Catheters Go Head-to-Head With PICCs for Bloodstream Infections
(MedPage Today) -- Incidence of bloodstream infections was not significantly different when midline catheters (MCs) or peripherally inserted central catheters (PICCs) were used for medium- to long-term IV therapy, a randomized trial found, but... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - February 13, 2024 Category: Infectious Diseases Source Type: news
IV DRIPS Customized IV Hydration & amp; Wellness Now Offering Sacramento, CA, Residents Premier Mobile Intravenous Therapy Service
IV DRIPS is excited to provide concierge, on-demand in-home drips, hydration drips, hangover drips, immunity drips and more to clients in Sacramento. SACRAMENTO, Calif., Dec. 4, 2023 /PRNewswire-PRWeb/ -- IV DRIPS Customized IV Hydration & Wellness is thrilled to announce its expansion... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - December 4, 2023 Category: Pharmaceuticals Tags: PDT Source Type: news
Cutting-Edge IV Therapy is Officially Touching Down in Phoenix!
We are excited to announce that The DRIPBaR Phoenix Biltmore will be opening next week on August 21st! The DRIPBaR is a nationwide franchise focused on helping people obtain their best physical and mental health through IV vitamin therapy. To celebrate their grand opening, The DRIPBaR... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 21, 2023 Category: Pharmaceuticals Tags: CXP Source Type: news
IV therapy is soaring in popularity, but it's not without risks. Experts explain the pros and cons
Whether you’re suffering from a hangover, fatigue, or jet lag, chances are there’s IV therapy for that. Favored among celebrities such as Rihanna, Chrissy Teigen and Simon Cowell, the intravenous treatments have become more prevalent than ever before with boutique clinics and mobile options…#rihanna #simoncowell #iv #ivdrip #nad #kardashians #haileybeiber #roberthshmerling #joepalumbo #hydreight (Source: Reuters: Health)
Source: Reuters: Health - May 6, 2023 Category: Consumer Health News Source Type: news
Gwyneth Paltrow Touts IV Therapy, Here Are The Problems
On a podcast, Paltrow said, “I love an IV!” IV lounges and wellness spas have been popping up around the country. But should you fall for such a line? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 18, 2023 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Lifestyle /lifestyle & Beauty /style-beauty business pharma Source Type: news
9 Wellness Trends to Ditch in 2023
In 2022, social media inspired many of the ways we tried to get and stay healthy—but not always for the better. Weight-loss drugs spread like wildfire online, as did our collective agreement to stop going the extra mile at work. We turned to Dr. TikTok again and again, and focused perhaps too much on body image—even when we tried to keep things positive.
The new year is the perfect time to re-evaluate these habits, experts say. Here are nine wellness trends you’d be better off ditching in 2023—plus healthier alternatives.
Weight-loss shots
Ozempic and Wegovy, two weight-loss injections that are used...
Source: TIME: Health - December 12, 2022 Category: Consumer Health News Tags: Uncategorized healthscienceclimate Research Wellbeing Source Type: news
Zydus buys rights from Pharmacosmos to sell drug to treat anemia in India, Nepal
MonoFerric injection is a rapid, single dose intravenous therapy used for the treatment of iron deficiency in adult patients when oral iron preparations are ineffective or cannot be used. MonoFerric is available in over 30 countries including US and Europe and over 28 million doses have been administered since launch. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 9, 2022 Category: Pharmaceuticals Source Type: news
Why Not Everyone Should Take Paxlovid
It’s getting harder to avoid COVID-19, thanks to the dominance of BA.5 in the U.S. and the growing number of other Omicron subvariants. Fortunately, Pfizer’s antiviral treatment Paxlovid can minimize illness from the disease.
But it’s not meant for everyone. Only those who are at increased risk for severe disease from COVID-19 qualify for the drug, including people over age 12 who have weakened immune systems or other health conditions that increase risk of serious effects of COVID-19—like asthma, cancer, liver disease, lung disease, heart disease, and obesity. Paxlovid also comes with a list of pot...
Source: TIME: Health - July 22, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Cincinnati startup key player in $330M Blackstone-backed drug collaboration
"This is something that has the potential to replace most IV therapy — and that, to me, is one of the biggest disruptions that I've ever seen in health care.” (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 10, 2022 Category: American Health Authors: Liz Engel Source Type: news
Evaluation of intravenous to oral antimicrobial switch at a hospital with a tightly regulated antimicrobial stewardship program
Australian study (n=107) found a median duration of IV therapy of 3 days, with timely IV-oral switch occurring in 57% of patients. Authors state excessive IV antimicrobial duration was uncommon, but total duration of antibiotic therapy was identified as a target (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 29, 2021 Category: Consumer Health News Source Type: news
Bayers-new-symptomatic-chronic-heart-failure-treatment-Verquvo-vericiguat-approved-in-EU
Approved for adult patients with reduced ejection fraction who are stabilized after a recent decompensation event requiring intravenous therapy / Studied in a population with a high risk of cardiovascular death or heart failure hospitalization / The sGC-stimulator Verquvo provides a specific approach to managing chronic heart failure following a decompensation event (Source: Bayer Company News)
Source: Bayer Company News - July 21, 2021 Category: Pharmaceuticals Source Type: news
One of Dayton's largest physician groups to build new care facility
The health center will feature sixteen exam rooms, spacious waiting areas and a dedicated lab space, as well as procedure, consultation and IV therapy rooms. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 2, 2021 Category: American Health Authors: Jacob Fisher Source Type: news
Positive-CHMP-opinion-for-Bayers-new-symptomatic-chronic-heart-failure-treatment-vericiguat
Vericiguat is being considered for adult patients with reduced ejection fraction who are stabilised after a recent decompensation event requiring intravenous therapy / Vericiguat was studied in a population with a high risk of cardiovascular death or heart failure hospitalization / European Commission decision is expected in the coming months (Source: Bayer Company News)
Source: Bayer Company News - May 21, 2021 Category: Pharmaceuticals Source Type: news
IV therapy provider Wellness Flow scouting Columbus for expansion
A year-old provider of intravenous therapy in Dayton is looking at Columbus for expansion. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - February 15, 2021 Category: American Health Authors: Caleb Stephens Source Type: news
FDA Approves First Drug For Treatment Of Thyroid Eye Disease
The drug is administered via intravenous therapy (IV), with eight infusions over a six month period. Each infusion can take between an hour to an hour and a half. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 25, 2020 Category: Pharmaceuticals Authors: Dana Dovey, Contributor Source Type: news
